Close

Truist Securities Starts Marinus Pharmaceuticals (MRNS) at Buy

September 30, 2020 5:32 AM EDT Send to a Friend
Truist Securities analyst Joon Lee initiates coverage on Marinus Pharmaceuticals (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login